Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2014 Mar 28;2014:bcr2014203997. doi: 10.1136/bcr-2014-203997

Creutzfeldt-Jakob disease: typical imaging findings

Ricardo Felix-Morais 1, Luisa Costa Andrade 1, Olinda Rebelo 2
PMCID: PMC3975535  PMID: 24682142

Description

A 63-year-old woman, previously healthy, presented with a 2-month history of progressive memory impairment, disorientation and behavioural changes. Examination revealed dysphasia, cerebellar ataxia and hypertonia of her upper limbs. Stimulus-sensitive myoclonus was also noted. Head CT was normal. MRI study was performed and revealed symmetric bilateral hyperintensities in putamen and caudate nucleus on T2-weighted (figure 1) images and fluid-attenuation inversion recovery (figure 2). On diffusion-weighted imaging, striatum and cortical frontotemporal gyriform hyperintense areas (cortical ribboning) were noted (figure 3), with restricted diffusion on apparent diffusion coefficient maps.

Figure 1.

Figure 1

Axial T2-weigthed images: bilateral hyperintense signal in the caudate and putamen.

Figure 2.

Figure 2

Axial fluid-attenuation inversion recovery: symmetric bilateral hyperintensity in the caudate and putamen.

Figure 3.

Figure 3

Diffusion-weighted imaging: diffusion restriction in the caudate nuclei and putamen. There is also typical hyperintensity in frontal and temporal lobe (‘cortical ribbons’).

The rapidly progressive dementia associated with the typical imaging findings, was strongly suggestive of Creutzfeldt-Jakob disease (CJD).1

The disease progressed relentlessly, with rapid cognitive and functional impairment towards akinetic mutism. The patient died 3 months after her admission. Postmortem brain autopsy revealed the presence of abnormal protease-resistant prion protein (figure 4), confirming the diagnosis.

Figure 4.

Figure 4

Immunostaining of protease-resistant prion protein.

CJD, is a rare neurodegenerative disease, with an incidence of 1:1 000 000/year worldwide.2 Sporadic CJD is caused by prion, an abnormal isoform of a normal host-encoded protein, leading to a spongiform encephalopathy.

The sporadic form is the most common (90%), but hereditary (10%) and acquired forms also exist (<1%).2 Typically, symptom onset occurs at sixth to seventh decade, with rapidly progressive dementia associated with myoclonic jerks and a variable constellation of pyramidal, extrapyramidal and cerebellar signs.3 Rapid progression towards akinetic mutism is the rule. Death usually ensues within months of clinical onset, with less than 10% rate survival within the first year.2 No effective treatment exists.

Learning points.

  • A rapidly progressive dementia associated with myoclonic jerks, pyramidal, extrapyramidal or cerebellar signs, is suggestive of Creutzfeldt-Jakob disease.

  • Best imaging tool: MRI with fluid-attenuation inversion recovery (FLAIR) and diffusion-weighted imaging (DWI).

  • Best imaging clues
    • T2-weighted and FLAIR: bilateral hyperintense signal in basal ganglia.
    • DWI: hyperintensity in basal ganglia and cortex.

Footnotes

Contributors: RF-M and LCA wrote the final version of the article. OR realised the biopsy. RF-M, LCA and OR contributed with significant revision to the article. All authors read and approved the final manuscript.

Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Johnson R, Gibbs C., Jr Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994–2004 [DOI] [PubMed] [Google Scholar]
  • 2.Kojima G, Tatsuno B, Inaba M, et al. Creutzfeldt-Jakob disease: a case report and differential diagnoses. Hawaii J Med Public Health 2013;72:136. [PMC free article] [PubMed] [Google Scholar]
  • 3.Zerr I, Kallenberg K, Summers D, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009;132:2659–68 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES